mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option
Recombinant technology has been around for nearly three quarters of a century and has revolutionized protein therapy. However, the cost of developing recombinant therapeutic proteins and the manufacturing infrastructure keeps their cost unaffordable for most patients. Proteins are produced in the bo...
Main Authors: | Sarfaraz K. Niazi, Matthias Magoola |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Biologics |
Subjects: | |
Online Access: | https://www.mdpi.com/2673-8449/3/4/20 |
Similar Items
-
RNA Therapeutics: A Healthcare Paradigm Shift
by: Sarfaraz K. Niazi
Published: (2023-04-01) -
Ribosome Specialization in Protozoa Parasites
by: Cristian Camilo Rodríguez-Almonacid, et al.
Published: (2023-04-01) -
mRNA therapeutics: New vaccination and beyond
by: Huan-Huan Wei, et al.
Published: (2023-09-01) -
Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates
by: Adele Francis Xu, et al.
Published: (2023-06-01) -
mRNA stem-loops can pause the ribosome by hindering A-site tRNA binding
by: Chen Bao, et al.
Published: (2020-05-01)